Executive Order 14297: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients

This executive order aims to bring fairness to prescription drug pricing by ensuring Americans pay no more than patients in other developed nations. It directs federal agencies to push for “most-favored-nation” pricing and warns drug companies that failure to comply may trigger importation reforms, antitrust enforcement, and tighter regulatory scrutiny. The order also targets global price discrimination and directs steps to prevent U.S. consumers from subsidizing foreign healthcare systems. The message is clear: American patients should get the best deal, not the highest bill.